ADMA Biologics Inc
NASDAQ:ADMA

Watchlist Manager
ADMA Biologics Inc Logo
ADMA Biologics Inc
NASDAQ:ADMA
Watchlist
Price: 19.84 USD 0.35% Market Closed
Market Cap: 4.7B USD

Intrinsic Value

The intrinsic value of one ADMA stock under the Base Case scenario is 12.66 USD. Compared to the current market price of 19.84 USD, ADMA Biologics Inc is Overvalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ADMA Intrinsic Value
12.66 USD
Overvaluation 36%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ADMA Biologics Inc

Valuation History Unavailable

Historical valuation for ADMA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about ADMA Biologics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ADMA Biologics Inc

Current Assets 351.8m
Cash & Short-Term Investments 71.6m
Receivables 99.4m
Other Current Assets 180.8m
Non-Current Assets 158.8m
PP&E 65.7m
Intangibles 4m
Other Non-Current Assets 89m
Efficiency

Free Cash Flow Analysis
ADMA Biologics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ADMA Biologics Inc

Revenue
459.4m USD
Cost of Revenue
-217.8m USD
Gross Profit
241.5m USD
Operating Expenses
-90.7m USD
Operating Income
150.8m USD
Other Expenses
56m USD
Net Income
206.8m USD
Fundamental Scores

ADMA Profitability Score
Profitability Due Diligence

ADMA Biologics Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional ROE
Exceptional ROIC
ROE is Increasing
54/100
Profitability
Score

ADMA Biologics Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

ADMA Solvency Score
Solvency Due Diligence

ADMA Biologics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

ADMA Biologics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ADMA Price Targets Summary
ADMA Biologics Inc

Wall Street analysts forecast ADMA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADMA is 26.25 USD with a low forecast of 21.17 USD and a high forecast of 33.6 USD.

Lowest
Price Target
21.17 USD
7% Upside
Average
Price Target
26.25 USD
32% Upside
Highest
Price Target
33.6 USD
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ADMA Biologics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ADMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ADMA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ADMA stock?

The intrinsic value of one ADMA stock under the Base Case scenario is 12.66 USD.

Is ADMA stock undervalued or overvalued?

Compared to the current market price of 19.84 USD, ADMA Biologics Inc is Overvalued by 36%.

Back to Top